Skip to main content Skip to section navigation Skip to footer

Lucid Diagnostics Inc.

  • Investors
  • Company

    • About Us
    • Leadership
    • Medical Advisory Board
    • Careers
  • Products

    • EsoCheck
    • EsoGuard
  • Clinical

    • BETRNet
    • References
  • Investor Relations
  • Contact

Press Releases

Investors

Investors

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Management Team
    • Presentations
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
    • Board Diversity Matrix
  • News & Events

  • Overview
  • Press Releases
  • IR Calendar
  • Email Alerts
Mar 04, 2022 8:25am EST

Lucid Diagnostics to Participate in the LSI USA ’22 Emerging Medtech Summit

Mar 03, 2022 8:25am EST

PAVmed Subsidiary Lucid Diagnostics Launches LucidDx Labs to Accommodate EsoGuard Testing Growth

Feb 10, 2022 8:25am EST

Lucid Diagnostics to Participate in a Fireside Chat at the BTIG MedTech Digital Health, Life Science, and Diagnostics Tools Conference

Jan 12, 2022 8:25am EST

PAVmed and Lucid Diagnostics Welcome New Full-Time Investor Relations Team

Jan 06, 2022 8:30am EST

Lucid Diagnostics to Participate in a Fireside Chat at the 24th Annual Needham Virtual Growth Conference

Dec 01, 2021 8:30am EST

PAVmed Subsidiary Lucid Diagnostics Launches EsoGuard Telemedicine Program in Partnership with UpScriptHealth

Nov 17, 2021 8:30am EST

Lucid Diagnostics to Present at Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services Forum

Nov 16, 2021 4:13pm EST

PAVmed and Lucid Provide Business Update and Preliminary Third Quarter 2021 Financial Results

Nov 11, 2021 8:30am EST

PAVmed Subsidiary Lucid Diagnostics Launches Next Phase of Lucid Test Centers

Nov 03, 2021 8:30am EDT

PAVmed and Lucid to Hold Joint Business Update Conference Call on November 16, 2021

  • arrow_back
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • arrow_forward
rss_feedNews RSS
  • Email Alerts
  • Contacts
  • RSS News Feed

One Grand Central Place, Suite 4600
New York, NY 10165

Email: info@LucidDX.com

212-949-4319

  • White Twitter Icon
  • White LinkedIn Icon
  • ©2023 Lucid Diagnostics Inc. All Rights Reserved.
  • Privacy Policy